Conroy Kevin T's Form 4 filing
Exact Sciences Corp (EXAS) · filed Feb 23, 2024
- Accession no.
- 0001209191-24-003918
- Filed
- Feb 23, 2024
- Trade date
- Feb 21-22, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $691.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Conroy Kevin TCIK 0001306119 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 21, 2024 | Common Stock | AGrant or awardAcquired | +23,238 | $0.00 | $0 | 1,252,994 | Direct | |
| Feb 22, 2024 | Common Stock | SSaleDisposed | −11,565 | $59.78 | −$691,355.7 | 1,241,429 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.